Skip to main content
Clinical Trials/NCT04266782
NCT04266782CompletedNot Applicable

ParKinWalk: Physical Activity and Long Group-walking for Motor Impairment and Quality of Life in Parkinson's Disease

Università degli Studi di Brescia1 site in 1 country40 target enrollmentStarted: May 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
1
Primary Endpoint
Supervised gait performance dual task gait

Study Overview

Brief Summary

The study will evaluate the impact of exercise training program followed by long-walking onon supervised and unsupervised gait assessment in Parkinson´s disease and control subjects.

Detailed Description

Background: Several studies suggest an impact of physical exercise on walking parameters in Parkinson´s disease (PD) patients.

Objective

the present study will evaluate the impact of three months physical exercise training program followed by a group-long walking on motor impairment in PD.

Methods:

PD patients will be randomized in two arms: one group will be assessed to a training exercise program of three months followed by long-walking in group under the support of physician/physiotherapist and caregivers. A complete motor, cognitive and general assessment will be performed at baseline. The patients will be evaluated under supervised an unsupervised conditions at baseline, before the long-walking, during the walking and after 2 months after the walk.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Masking Description

The clinician and outcome assessors at the beginning and after the training/no intervention will not have access to the assigned arm

Eligibility Criteria

Ages
30 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Parkinson´s disease diagnosis
  • •stable dopaminergic treatment ( stable dose in the last three months before baseline evaluation)

Exclusion Criteria

  • •gait impairment due to other medical conditions
  • •impulsive compulsive disorder
  • •severe depression

Arms & Interventions

Physical exercise program and Long-walking

Experimental

A physical training will be started three months before the long-walking. The subjects will have to walk for at least 3 hours per week up to 6 hours per week during the training. THe long-distance capacity will be verified in 3 different one-day walking of 10, 15 and 18 Km before the long-walking performance.

The long-walking will be organized with the support of a physician, study nurse, physiotherapy with car support in case of need. The subject are request to complete the walk of 104 Km of Portuguese route of Santiago de Compostela walk.

Intervention: Exercise program followed by long walk in group (Other)

Usual care

No Intervention

The subjects will be followed according to current standard.

Control group-intervention

Active Comparator

A physical training will be started three months before the long-walking. The subjects will have to walk for at least 3 hours per week up to 6 hours per week during the training. THe long-distance capacity will be verified in 3 different one-day walking of 10, 15 and 18 Km before the long-walking performance.

The long-walking will be organized with the support of a physician, study nurse, physiotherapy with car support in case of need. The subject are request to complete the walk of 104 Km of Portuguese route of Santiago de Compostela walk.

Intervention: Exercise program followed by long walk in group (controls) (Other)

Outcomes

Primary Outcomes

Supervised gait performance dual task gait

Time Frame: Changes between baseline, immediately before the long-walking, during the day 1 and day 5 of walk and two months after walk. In the non-active group- supervised and unsupervised assessment will be evaluated after 6 months of usual care.

Step variability using wearing sensors technology in one-minute supervised dual task walking (Rehagait Hasomed as wearing sensors)

unsupervised gait performance normal gait

Time Frame: Changes between baseline, immediately before the long-walking, during the day 1 and day 5 of walk and two months after walk. In the non-active group- supervised and unsupervised assessment will be evaluated after 6 months of usual care.

Step variability using wearing sensors technology in one-day unsupervised walking (GaitUp Physilog sensors)

Supervised gait performance normal gait

Time Frame: Changes between baseline, immediately before the long-walking, during the day 1 and day 5 of walk and two months after walk In the non-active group- supervised and unsupervised assessment will be evaluated after 6 months of usual care.

Step variability using wearing sensors technology in one-minute supervised walking (rehagait, Hasomed as wearing sensors)

Secondary Outcomes

  • Unified parkinson´s disease Rating Scale part 3 (0-132 points) Higher scores mean worse outcomes(Changes between baseline, immediately before the long-walking, during the day 1 and day 5 of walk and two months after walk. In the non-active group- the assessment will be evaluated at baseline and after 6 months of usual care.)
  • Parkinson´s disease Quality of life questionnaire (PDQ-39) (0-117 points) Lower scores mean worse outcomes(Changes between baseline, immediately before the long-walking, during the day 1 and day 5 of walk and two months after walk. In the non-active group- the assessment will be evaluated at baseline and after 6 months of usual care.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Andrea Pilotto

Principal Investigator

Università degli Studi di Brescia

Study Sites (1)

Loading locations...

Similar Trials